- Abstract:
-
Radiotherapy is a major treatment modality used to treat muscle-invasive bladder cancer, with patient outcomes similar to surgery. However, radioresistance is a significant factor in treatment failure. Cell-free extracts of muscle-invasive bladder tumors are defective in nonhomologous end-joining (NHEJ), and this phenotype may be used clinically by combining radiotherapy with a radiosensitizing drug that targets homologous recombination, thereby sparing normal tissues with intact NHEJ. The re...
Expand abstract - Publication status:
- Published
- Journal:
- Cancer research
- Volume:
- 73
- Issue:
- 5
- Pages:
- 1611-1620
- Publication date:
- 2013-03-05
- DOI:
- EISSN:
-
1538-7445
- ISSN:
-
0008-5472
- URN:
-
uuid:fd6ee70a-2cdb-41d6-979f-43836606b95b
- Source identifiers:
-
374277
- Local pid:
- pubs:374277
- Language:
- English
- Keywords:
- Copyright date:
- 2013
Journal article
Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record